The prevalence and risk-factors of oral HPV DNA detection among HIV-infected men between men who have sex with men and heterosexual men.


Journal

Infectious diseases (London, England)
ISSN: 2374-4243
Titre abrégé: Infect Dis (Lond)
Pays: England
ID NLM: 101650235

Informations de publication

Date de publication:
Jan 2021
Historique:
pubmed: 12 9 2020
medline: 1 6 2021
entrez: 11 9 2020
Statut: ppublish

Résumé

Human papillomavirus (HPV)-associated oropharyngeal carcinomas are becoming more common with epidemiological impact on human immunodeficiency virus (HIV)- positive individuals.

Sections du résumé

BACKGROUND BACKGROUND
Human papillomavirus (HPV)-associated oropharyngeal carcinomas are becoming more common with epidemiological impact on human immunodeficiency virus (HIV)- positive individuals.

Identifiants

pubmed: 32915107
doi: 10.1080/23744235.2020.1811373
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-30

Auteurs

Helena M Gonçalves (HM)

Public Health Unit, Agrupamento de Centros de Saúde (ACES), Lisboa Ocidental e Oeiras, Lisbon, Portugal.

Jani Silva (J)

Molecular Oncology & Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.

Inês Pintado Maury (I)

Infectious Disease Service, Centro Hospitalar Lisboa Norte, EPE, Hospital de Santa Maria, Lisbon, Portugal.

Ana Tavares (A)

Virology Service, Portuguese Oncology Institute of Porto, Porto, Portugal.

Carla Campos (C)

Virology Service, Portuguese Oncology Institute of Porto, Porto, Portugal.

Hugo Sousa (H)

Molecular Oncology & Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.
Virology Service, Portuguese Oncology Institute of Porto, Porto, Portugal.

Amado Jacinto (A)

Public Health Unit, Agrupamento de Centros de Saúde (ACES), Lisboa Ocidental e Oeiras, Lisbon, Portugal.

Pedro Aguiar (P)

Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.

Luís Caldeira (L)

ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.

Rui Medeiros (R)

Molecular Oncology & Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.
Infectious Disease Service, Centro Hospitalar Lisboa Norte, EPE, Hospital de Santa Maria, Lisbon, Portugal.
Virology Service, Portuguese Oncology Institute of Porto, Porto, Portugal.
Nacional School of Public Heath, New University of Lisbon, Lisbon, Portugal.
FP-ENAS Research Unit, UFP Energy, Environment and Health Research Unit, CEBIMED Fernando Pessoa University, Porto, Portugal.
LPCC, Research Department, Portuguese League Against Cancer (LPPC - NRN), Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH